Many people who live with severe food and other allergies can take part in a class action lawsuit against the makers of EpiPen, the potentially life-saving auto-injector.

The plaintiffs claim Mylan, Pfizer and other defendants raised the EpiPen price more than 500% and tried to limit competition in a number of ways. For example, they allegedly gave insurance companies perks not to reimburse other brands.

Consumers were outraged over the price and that federal lawmakers ultimately held hearings on the issue.

The class action lawsuit has two classes. Maybe you fit in to one or both:

One involves the federal racketeering law. You qualify if you bought EpiPens after August 24, 2011.

The other involves state anti-trust laws. You qualify if you bought EpiPens after January 28, 2013, but only in certain states. North Carolina is one. South Carolina is not.

If you want to be part of this case: don’t do anything.

If you don’t want to be part of the case (maybe you’d rather sue on your own): You have to opt out of the case by January 15, 2021. Here’s the link.

The trial is set for April.

Breakthrough treatment could help people tolerate foods they're allergic to Breakthrough treatment could help people tolerate foods they're allergic to

Cox Media Group

ncG1vNJzZmivp6x7uL%2FOnKuvZpOkunC6xLCqaKSfmK6te8eormaskaCybrzAq6tmp6Jiu7DAjJ6noqiVo3qkuMCsqmaZk6m2sLqMpZiwq6WewXCCoY6OkGtjiZGDj7OBhYiGhIuBiJSrjYCThV8%3D